We are live on
!
Find out more
CC
Capital Counsel Portfolio holdings
AUM
$2.35B
1-Year Est. Return
21.34%
This Fund
S&P 500
This Quarter
Est. Return
-17.04%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$1.64B
AUM Growth
-$464M
(-22%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-6.21%
Top 10 Holdings %
Top 10 Hldgs %
89.74%
Holding
56
New
–
Increased
6
Reduced
18
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$5.33M |
| 2 |
Microsoft
MSFT
|
+$499K |
| 3 |
Mettler-Toledo International
MTD
|
+$325K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$142K |
| 5 |
Moderna
MRNA
|
+$3.43K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$60.2M |
| 2 |
Edwards Lifesciences
EW
|
+$27.1M |
| 3 |
Qualcomm
QCOM
|
+$10.8M |
| 4 |
Costco
COST
|
+$3.67M |
| 5 |
Home Depot
HD
|
+$2.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.28% |
| 2 | Technology | 24.47% |
| 3 | Financials | 19.28% |
| 4 | Consumer Staples | 10.95% |
| 5 | Communication Services | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Vuzix
VUZI
$194M
| $142K | 0.01% |
20,000
| – | – |
|
52
Walt Disney
DIS
$167B
| – | – |
-1,636
| Closed | -$224K |
|
|
53
Johnson & Johnson
JNJ
$618B
| – | – |
-339,630
| Closed | -$60.2M |
|
54
Exicure
XCUR
$10.2M
| – | – |
-100
| Closed | -$3K |
|
55
Zoetis
ZTS
$32.4B
| – | – |
-1,500
| Closed | -$283K |
|
|
POLY
56
DELISTED
Plantronics, Inc.
POLY
| – | – |
-6,000
| Closed | -$236K |
|
Similar funds
HFM
ROIC
EC
SCA
G
MC
BAM
BJL
Capital Counsel's Q2 2022 Portfolio in Review
As of Q2 2022, Capital Counsel held 56 positions worth $1.64B, down 22% from $2.1B the previous quarter. Its ten largest holdings account for 90% of the portfolio.
Capital Counsel withdrew a net $102M in Q2 2022, closing 5 positions and reducing 18 holdings. Its most notable exit was Johnson & Johnson, an estimated $60.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 34% a quarter earlier, followed by Technology and Financials.
Against the trend, Capital Counsel added an estimated $5.33M to Idexx Laboratories.
- Capital Counsel added most to Idexx Laboratories in Q2 2022, an estimated $5.33M increase.
- Capital Counsel's biggest Q2 2022 reduction was Edwards Lifesciences, cutting an estimated $27.1M.
- Capital Counsel fully exited Johnson & Johnson in Q2 2022, selling an estimated $60.2M.
- Capital Counsel's ten largest holdings make up 90% of its $1.64B portfolio in Q2 2022.
- Capital Counsel opened 0 new positions and closed 5 in Q2 2022.
- Capital Counsel's portfolio value fell 22% quarter-over-quarter to $1.64B.
Based on Capital Counsel's 13F filing for Q2 2022, filed 15 Aug 2022.